Canada Goose (GOOS) Falls More Steeply Than Broader Market: What Investors Need to Know

Canada Goose (GOOS) recently closed at $13.29, falling 1.7% and significantly underperforming the broader market and its sector over the past month with a 4.38% decline. For its upcoming earnings, the company projects a -$0.05 EPS, representing a 225% year-over-year decrease, though revenue is expected to climb 6.36% to $208.8 million, with full-year estimates showing positive growth for both metrics. Despite its industry ranking in the bottom 40%, GOOS trades at a Forward P/E of 13.73, a discount to the industry average of 17.6, and holds a favorable PEG ratio of 1.01, contributing to its Zacks Rank #2 (Buy).

Analysis

Canada Goose (GOOS) presents a bifurcated investment profile, characterized by recent stock underperformance juxtaposed with a positive forward-looking outlook and attractive valuation. The shares have declined 4.38% over the past month, significantly lagging the Retail-Wholesale sector's 0.66% gain and the S&P 500's 2.74% advance. This weakness precedes an upcoming earnings report where a substantial 225% year-over-year decrease in EPS to -$0.05 is anticipated, signaling significant near-term margin pressure. However, this is partially offset by a projected 6.36% rise in quarterly revenue to $208.8 million. The market appears to be focused on the full-year trajectory, for which consensus estimates call for a 23.75% increase in EPS and an 8.22% rise in revenue. From a valuation standpoint, GOOS trades at a discount with a Forward P/E of 13.73 versus the industry's 17.6, and its PEG ratio of 1.01 is notably more favorable than the industry average of 2.32, suggesting the price may be reasonable relative to its growth prospects. While the stock holds a Zacks Rank #2 (Buy), it operates in a poorly ranked industry (bottom 40%), and the lack of recent changes to consensus EPS estimates indicates a stable but not improving analyst sentiment.

Key Decisions for Investors

• Investors should scrutinize the upcoming earnings announcement, focusing on whether management's full-year guidance reaffirms the projected 23.75% EPS growth, which is essential to justify looking past the expected quarterly loss.
• The recent stock underperformance, coupled with a discounted forward P/E of 13.73 and a PEG ratio of 1.01, may present an opportunity for long-term oriented investors who believe in the company's full-year recovery narrative.
• Monitor for any negative revisions to analyst estimates post-earnings, as the current bullish case hinges heavily on the full-year outlook materializing despite the stock's weak industry backdrop and the severe projected quarterly earnings decline.